Shankar Musunuri - 03 Jan 2022 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role: Chief Executive Officer, Director
Signature: /s/ Shankar Musunuri by Sanjay Subramanian, his attorney-in-fact
Issuer symbol: OCGN
Transactions as of: 03 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 05 Jan 2022, 18:32:25 UTC
Previous filing: 17 Dec 2021
Next filing: 16 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCGN	Common Stock	Award	$0	+346,540	+85%	$0.000000	752,540	03 Jan 2022	Direct	F1
holding	OCGN	Common Stock						1,145,299	03 Jan 2022	By: KVM Holdings, LLC	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCGN	Option (Right to Buy)	Award	$0	+1,253,299		$0.000000	1,253,299	03 Jan 2022	Common Stock	1,253,299	$4.72	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Ocugen Inc.'s (the "Company's") common stock. The restricted stock units vest annually in three equal installments commencing on January 3, 2023, subject to continued employment with the Company on the applicable vesting dates. The restricted stock units will be settled on each applicable vesting date in shares of the Company's common stock.
F2	The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC.
F3	The option vests annually in equal installments over three years commencing on January 3, 2023, subject to continued employment with the Company on the applicable vesting dates.